KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Inventory: 2020-2025

Historic Inventory for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Sep 2025 value amounting to $44.8 million.

  • Aurinia Pharmaceuticals' Inventory rose 15.70% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.8 million, marking a year-over-year increase of 15.70%. This contributed to the annual value of $39.2 million for FY2024, which is 1.20% down from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Inventory of $44.8 million as of Q3 2025, which was down 3.68% from $46.5 million recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Inventory peaked at $46.5 million during Q2 2025, and registered a low of $15.9 million during Q1 2021.
  • Moreover, its 3-year median value for Inventory was $39.2 million (2024), whereas its average is $39.2 million.
  • As far as peak fluctuations go, Aurinia Pharmaceuticals' Inventory spiked by 185.53% in 2021, and later declined by 1.20% in 2024.
  • Aurinia Pharmaceuticals' Inventory (Quarterly) stood at $19.3 million in 2021, then increased by 28.08% to $24.8 million in 2022, then surged by 60.41% to $39.7 million in 2023, then fell by 1.20% to $39.2 million in 2024, then climbed by 15.70% to $44.8 million in 2025.
  • Its Inventory was $44.8 million in Q3 2025, compared to $46.5 million in Q2 2025 and $46.2 million in Q1 2025.